{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:30:07Z","timestamp":1793464207469,"version":"4.5.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Many reports have described the use of botulinum toxin (BTX) in the treatment of scalp conditions, but no studies have synthesized these collective findings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>We conducted a systematic review to summarize the scalp conditions for which treatment with BTX has been described.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>We searched PubMed\/MEDLINE and Scopus for articles in English published before November 1, 2022, using the keywords \u201chair\u201d or \u201cscalp\u201d and BTX-related search terms. Articles that described patients who received injections of BTX for the management of scalp conditions were included.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>Twenty-four original articles (12 case reports, 9 clinical trials, and 3 case series) were identified that described 309 patients with a scalp condition treated with BTX. Androgenetic alopecia, craniofacial hyperhidrosis, and scalp hyperseborrhea had the most robust data supporting the clinical efficacy of BTX.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>The current quality of evidence is highly variable and, for many conditions, limited to small observational studies. Botulinum toxin may be a promising therapeutic option for patients with various scalp conditions, but future studies are needed to better understand its efficacy and safety.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000003895","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T13:08:50Z","timestamp":1691586530000},"page":"1023-1026","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Botulinum Toxin for Scalp Conditions: A Systematic Review"],"prefix":"10.1097","volume":"49","author":[{"given":"Betty","family":"Nguyen","sequence":"first","affiliation":[{"name":"Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida;"},{"name":"University of California Riverside School of Medicine, Riverside, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia M.","family":"Perez","sequence":"additional","affiliation":[{"name":"Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Tosti","sequence":"additional","affiliation":[{"name":"Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,8,8]]},"reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1468-1331.2001.00035.x","article-title":"Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions","volume":"8","author":"AokiGuyer","year":"2001","journal-title":"Eur J Neurol"},{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/1501893","article-title":"Effectiveness and safety of botulinum toxin type A in the treatment of androgenetic alopecia","volume":"2020","author":"Zhou","year":"2020","journal-title":"Biomed Res Int"},{"key":"R3-20250731","doi-asserted-by":"crossref","first-page":"246e","DOI":"10.1097\/PRS.0b013e3181ef816d","article-title":"Treatment of male pattern baldness with botulinum toxin: a pilot study","volume":"126","author":"Freund","year":"2010","journal-title":"Plast Reconstr Surg"},{"key":"R4-20250731","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1111\/jocd.15179","article-title":"A study of combination unilateral subcutaneous botulinum toxin a treatment for androgenetic alopecia","volume":"21","author":"Tian","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4103\/JCAS.JCAS_77_17","article-title":"A pilot study to evaluate effectiveness of botulinum toxin in treatment of androgenetic alopecia in males","volume":"10","author":"Neema","year":"2017","journal-title":"J Cutan Aesthet Surg"},{"key":"R6-20250731","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1111\/jocd.14817","article-title":"Efficacy of botulinum toxin A injection in the treatment of androgenic alopecia: a Comparative Controlled Study","volume":"21","author":"Nassar","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.jaad.2020.04.082","article-title":"The effect of intradermal botulinum toxin on androgenetic alopecia and its possible mechanism","volume":"83","author":"Shon","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"e15720","DOI":"10.1111\/dth.15720","article-title":"Recent modalities in treatment of telogen effluvium: comparative study","volume":"35","author":"Khattab","year":"2022","journal-title":"Dermatol Ther"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1111\/j.1524-4725.2010.01709.x","article-title":"Treatment effects of intradermal botulinum toxin type A injection on alopecia areata","volume":"36","author":"Cho","year":"2010","journal-title":"Dermatol Surg"},{"key":"R10-20250731","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1464-410X.2007.07312.x","article-title":"Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation","volume":"101","author":"Lucioni","year":"2008","journal-title":"BJU Int"},{"key":"R11-20250731","first-page":"1398","article-title":"Letter: folliculitis responds to botulinum toxin: is it possible?","volume":"33","author":"Tamura","year":"2007","journal-title":"Dermatol Surg"},{"key":"R12-20250731","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11916-020-00880-w","article-title":"Cephalgia alopecia","volume":"24","author":"Bedrin","year":"2020","journal-title":"Curr Pain Headache Rep"},{"key":"R13-20250731","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1468-2982.2009.01987.x","article-title":"Botulinum toxin treatment of cephalalgia alopecia increases substance P and calcitonin gene-related peptide-containing cutaneous nerves in scalp","volume":"30","author":"Cutrer","year":"2010","journal-title":"Cephalalgia"},{"key":"R14-20250731","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1468-2982.2006.01098.x","article-title":"Cephalalgic alopecia areata: a syndrome of neuralgiform head pain and hair loss responsive to botulinum A toxin injection","volume":"26","author":"Cutrer","year":"2006","journal-title":"Cephalalgia"},{"key":"R15-20250731","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/head.12072","article-title":"Cephalalgia alopecia or nummular headache with trophic changes? A new case with prolonged follow-up","volume":"53","author":"Irimia","year":"2013","journal-title":"J Head Face Pain"},{"key":"R16-20250731","doi-asserted-by":"crossref","first-page":"e15442","DOI":"10.1111\/dth.15442","article-title":"The combination of platelet-rich plasma with botulinum toxin A in the treatment of hyaluronic acid embolic cutaneous necrosis and alopecia","volume":"35","author":"Guo","year":"2022","journal-title":"Dermatol Ther"},{"key":"R17-20250731","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1159\/000502262","article-title":"Alopecia secondary to hyaluronic acid embolization: trichoscopic findings","volume":"5","author":"Asz-Sigall","year":"2019","journal-title":"Skin Appendage Disord"},{"key":"R18-20250731","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/jdv.12278","article-title":"Botulinum toxin B in the treatment of craniofacial hyperhidrosis","volume":"28","author":"Karlqvist","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R19-20250731","doi-asserted-by":"crossref","first-page":"030006052110042","DOI":"10.1177\/03000605211004213","article-title":"Effect of botulinum toxin in stellate ganglion for craniofacial hyperhidrosis: a case report","volume":"49","author":"Park","year":"2021","journal-title":"J Int Med Res"},{"key":"R20-20250731","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1440-0960.2012.00888.x","article-title":"Craniofacial hyperhidrosis in post-menopausal women","volume":"53","author":"Alsharqi","year":"2012","journal-title":"Australas J Dermatol"},{"key":"R21-20250731","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4103\/0378-6323.93647","article-title":"Hyperhidrosis of face and scalp: repeated successful treatment with botulinum toxin type A","volume":"78","author":"Komericki","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R22-20250731","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/ced.13310","article-title":"Postmenopausal craniofacial hyperhidrosis","volume":"43","author":"Eustace","year":"2018","journal-title":"Clin Exp Dermatol"},{"key":"R23-20250731","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00415-002-0929-4","article-title":"Botulinum toxin type B for treatment of axillar hyperhidrosis","volume":"249","author":"Dressler","year":"2002","journal-title":"J Neurol"},{"key":"R24-20250731","doi-asserted-by":"crossref","first-page":"100264","DOI":"10.1016\/j.omsc.2022.100264","article-title":"A unique case of primary focal hyperhidrosis and treatment","volume":"8","author":"Hannan","year":"2022","journal-title":"Oral Maxillofac Surg Cases"},{"key":"R25-20250731","doi-asserted-by":"crossref","first-page":"NP38","DOI":"10.1093\/asj\/sjac236","article-title":"Intradermal botulinum toxin A injection for scalp sebum secretion regulation: a multicenter, randomized, double-blinded, placebo-controlled, prospective study in Chinese subjects","volume":"43","author":"Li","year":"2022","journal-title":"Aesthet Surg J"},{"key":"R26-20250731","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/DSS.0000000000000812","article-title":"Improvement of \"en coup de Sabre\" morphea and associated headaches with botulinum toxin injections","volume":"42","author":"Rimoin","year":"2016","journal-title":"Dermatol Surg"},{"key":"R27-20250731","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1097\/IOP.0b013e31828de9c0","article-title":"Parry-Romberg syndrome vasculopathy and its treatment with botulinum toxin","volume":"30","author":"Borodic","year":"2014","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R28-20250731","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/JCAS.JCAS_197_20","article-title":"Botulinum toxin for scalp dysesthesia","volume":"15","author":"Lin","year":"2022","journal-title":"J Cutan Aesthet Surg"},{"key":"R29-20250731","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000173695","article-title":"Botulinum toxin type A--treatment of a patient with multiple cutaneous piloleiomyomas","volume":"218","author":"Sifaki","year":"2009","journal-title":"Dermatology"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000003895","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T22:02:00Z","timestamp":1753999320000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000003895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000003895","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,8]]}}}